chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lymphoma; This case was reported by a physician via call center representative and described the occurrence of lymphoma in a 4-year-old female patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   Previously administered products included Pediarix (1 dose received on 17th February 2005). Concomitant products included DTPa-HBV-IPV (Pediarix).   On 22nd June 2005, the patient received the 3rd dose of Pediarix. On 4th September 2009, 4 years and 75 days after receiving Pediarix, the patient experienced lymphoma (serious criteria GSK medically significant). On an unknown date, the outcome of the lymphoma was unknown.   It was unknown if the reporter considered the lymphoma to be related to Pediarix.  Additional details were provided as follows: The patient received her first three doses of Pediarix in 2005, but never completed the remainder of the DTaP or IPV due to being diagnosed with lymphoma.  They went into remission, but it came back at some point.  The patient completed their treatments about a year ago and was cleared to receive live vaccines. The reporter consented for follow up.
This am fever of 102.4, body aches, face looked "puffy" this am but has improved seems sluggish but not confused.
suspected vaccination failure; got shingles from the vaccine / case of shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient himself/herself. The age at vaccination was not reported. The patient received the dose of Shingles vaccine and got shingles. The reporter stated that it only cost him/her 100.00 dollar for a case of shingles and months of his/her life. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
The patient had a PMH of severe COPD s/p R lung transplant (2016), CKD 4, BK virus nephropathy, Stage III melanoma with Lymph node metastasis presented to a local ED following a ground-level fall on 2/17/2022 with left-sided weakness.  MRI did not show any clear evidence of an acute infarct.  Found to have C3-4 disc herniation with pre-existing spinal canal stenosis, s/p ACDF with neurosurgery on 2/25/22.  On 3/2/2022 the patient was found to have Covid-19 and treated with Dexamethasone and Remdesivir.  The patient then tested positive for C. diff 3/7/2022 and received PO vanc.  On 3/11/22 the patient became acutely hypoxic and was transferred to MICU and initiation on therapeutic anticoagulation for suspicion of PE.  The patient required intubation.  On 3/13 CRRT was initiated and had 2 L taken off with improvement in his oxygenation.  The patient continued to decline and was made DNR/DNI and expired on 3/17/2022.
Breast cancer; This is a spontaneous report from a contactable consumer (governor) reported for his wife. A female patient of an unspecified age received bnt162b2 (COVID-19 Vaccine - Manufacturer Unknown), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation.  The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced breast cancer on an unspecified date with outcome of unknown. The governor and his wife got the vaccine, didn't know what vaccine the patient received as they would have to ask the governor about that.  Pfizer is a marketing authorization holder of [COVID-19 Vaccine] in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of COVID-19 Vaccine  has submitted the same report to the regulatory authorities.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts  have been completed and no further information is expected
Saw OB on Jan 4 and there was a strong heartbeat and no defects or problems noted in any bloodwork up to that point in the pregnancy. Received my second vaccine on Jan 19. On Feb 3 I went to my next ultrasound appointment and was told that the baby had no heartbeat. It was estimated that the baby had likely passed a couple weeks prior but I am not certain of the timeline in regards to receiving the second vaccine.
Pt. states that after receiving the 1st dose of Phizer 07/15/2021, started experiencing symptoms that evening of a sore arm with pain radiating throughout the arm to hand. Experiencing HBP and edema in both feet.  Still continuing, received 2nd dose of 08/05/2021. Primary contact recommendation of elevation for the edema in the feet.
Cellulitis; This is a spontaneous report received from a contactable Other Health Professional (patient). A 47-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 26Feb2021 15:15 (Batch/Lot Number: Unknown) as single dose for COVID-19 immunisation. Medical history included asthma, GERD (gastrooesophageal reflux disease) and HTN (hypertension). Patient was allergy to Sulfa, mometasone furoate (NASONEX) and ciclesonide (OMNARIS). Concomitant medications included pantoprazole, prednisone, phentermine and more.  The patient experienced cellulitis "10 days" on 10Mar2021 with outcome of recovered. Patient received treatment included cefalexin (KEFLEX) then doxycycline. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Lab test on 27Mar2021 included RT-PCR of SARS-CoV-2 test and nasal swab were both negative.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: As there is limited information in the case provided, the causal association between the event of cellulitis and the suspect vaccine BNT162B2 cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Today, 7 days after the first shot, I woke up with the injection site red, very itchy, slightly swollen and hard.
Patient began having Thyroid problems after the 1st dose; Patient found out she was pregnant a month after 1st dose; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Patient found out she was pregnant a month after 1st dose) and THYROID DISORDER (Patient began having Thyroid problems after the 1st dose) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Breast feeding.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. In February 2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Patient found out she was pregnant a month after 1st dose). On an unknown date, the patient experienced THYROID DISORDER (Patient began having Thyroid problems after the 1st dose). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Delivered NOS. In February 2021, MATERNAL EXPOSURE DURING PREGNANCY (Patient found out she was pregnant a month after 1st dose) had resolved. At the time of the report, THYROID DISORDER (Patient began having Thyroid problems after the 1st dose) had not resolved.            No concomitant medication provided No treatment medication provided Patient was taking thyroid medicine for thyroid problems.   This case was linked to MOD-2022-464894 (Patient Link).
I got the single shot and the double shotssuspected vaccination failure; shingles; blisters; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and blister. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and blister were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and blister to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the Shingles shot and the double shots and still get the 2 or 3 blisters every few months and go figure. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Patients mother called instating that her daughter received a vaccine on 08/05/2019 and started running a fever on 08/07/2019. She had no other symptoms at this time. She was seen in urgent care and advised that fever was most likely from vaccine and teething. On 08/10/2019 the patients mother called back again and advised that the patient had a rash, possible due to an oat exposure. Mom was advised to give benadryl and to come in if pt had and flushing and/or respiratory concerns that developed.  We contacted patients mother the following day and the rash had cleared up a little bit. The patient had no further concerns or problems at this time.
Patient received a 4th dose of Hepatitis B vaccine on 9/13/2010.  Mother does not recall any signs or symptomns at that time.
Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and HEADACHE (Headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced NAUSEA (Nausea) and HEADACHE (Headache). On 13-Apr-2021, NAUSEA (Nausea) and HEADACHE (Headache) had resolved.            No Concomitant information  provided. No Treatment information  provided   This case was linked to MOD21-075780, MOD21-075706, MOD-2021-077197, INC.-MOD-2021-076718,-MOD-2021-076812 (E2B Linked Report).; Sender's Comments:  MOD21-075780: MOD21-075706: MOD-2021-077197:first dose
Exactly 30 days following my first dose of moderna, I experienced very heavy menstruation and severe cramping. I am on birth control continually and do not experience a period normally, so this was highly unusual for me. I have not received my second vaccine yet and I am not pregnant.
Information has been received from a physician concerning a 14 year old female with no pertinent medical history and no history of drug reactions or allergies who on 08-JUL-2008 was vaccinated with the first dose of GARDASIL vaccine. There was no concomitant medication. Subsequently, the patient had nausea and aches overnight and then developed a bilateral rash from her knees down to her feet. The physician stated there was no fever and the rash was fading on the day of the report. It was unspecified if the patient sought medical attention. Additional information has been requested. 10/08/08 This is in follow-up to report(s) previously submitted on 8/14/2008. Information has been received from a physician concerning a 14 year old female with no pertinent medical history and no history of drug reactions or allergies who on 08-JUL-2008 was vaccinated with the first dose of GARDASIL (lot#: 659964/1978U) into the arm. There was no concomitant medication. Subsequently, within 24 hours of the vaccination, the patient had nausea and aches overnight and then developed a bilateral rash from her knees to her feet. The physician stated there was no fever and the rash was fading on the day of the report. The symptoms cleared within the next 24 hours and the patient recovered. The patient didn't seek medical attention. Additional information is not expected.
INJECTION SITE SWELLING; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced injection site swelling. On APR-2021, the subject experienced injection site pain. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from injection site swelling, and injection site pain. This report was non-serious.
The vial the vaccine came from was punctured at 4:55pm on 8/31, so it was expired at 4:55am on 9/1.  Patient received a dose from this vial at 10:26am on 9/1.
R arm erythematous, swollen at site distal to where pneumococcal was given subcutaneously R arm given 8/15/02. Went to ER on 8/17/02 saw MD.
pt recvd vax; wheezing 1st noticed approx 1 hr p/ vax; approx 7 hrs later  devel fever; PC to MD; prescribed antihistamine & proventil;
(L) thigh red, swollen at site, warm to touch, hard and tender to touch.
Flu-like symptoms; Balance affected; Eyesight affected; Body stiff; Back ache; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), BALANCE DISORDER (Balance affected), VISUAL IMPAIRMENT (Eyesight affected), MUSCULOSKELETAL STIFFNESS (Body stiff) and BACK PAIN (Back ache) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rheumatoid arthritis (Rheumatoid arthritis, unspecified).    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), BALANCE DISORDER (Balance affected), VISUAL IMPAIRMENT (Eyesight affected), MUSCULOSKELETAL STIFFNESS (Body stiff), BACK PAIN (Back ache) and MYALGIA (Body ache). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), BALANCE DISORDER (Balance affected), VISUAL IMPAIRMENT (Eyesight affected), MUSCULOSKELETAL STIFFNESS (Body stiff), BACK PAIN (Back ache) and MYALGIA (Body ache) had resolved.            No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
She has experienced acne for the last 6 weeks/Nurse Prescriber noted that the patient had "cystic acne"; This spontaneous report was received from a nurse prescriber and refers to a 24 year old female patient. The patient did not have any concurrent condition, medical history, drug allergies/reactions or concomitant medications.  On 27-JUN-2019, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 dose (anatomical site of vaccination was not reported; route of administration, lot number and expiration date were unknown by the reporter) as Human Papillomavirus (HPV) vaccination.  On 27-JUN-2019 (also reported as the last 6 weeks, ever since a couple days after the injection), the patient experienced acne, then the nurse prescriber noted that the patient had acne cystic on the office visit, but no treatment was provided.  At the time of this report, the patient had not recovered from acne cystic.  The reporter stated that she did not believe that acne cystic  was related to HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast)(GARDASIL 9), but the patient had no other changes since receiving the shot.
Numbness left side of body. Primarily 1/2 of my lip and left eye. Neurological, treated with steroids.
Information has been received regarding a case in litigation concerning a male child who was injected with vaccinations containing the toxic mercury-based preservative thimerosal during his 1st year of life, from 2/97 through 1998, and each time he received a multi-dose vaccine. The alleged results of these vaccinations are that the pt sustained severe and permanent personal injuries, including being dx'd with severe autism and other neurological disorders. In addition, it is alleged that the pt has sustained further neurological insult from other vaccines, including MMRII, which does not contain thimerosal, but caused further neurological insult and exacerbated the neurological disorders from the prior thimerosal exposure. Upon internal review, permanent personal injuries, severe autism, neurological disorders and the exacerbation of the neurological disorders were considered to be "Other Important Medical Events". No further information is available.
distance vision loss began happening four days after being vaccinated; salivatory glands in mouth dried up, felt like sucking on lemons, nostrils became stuffed up. This was with in about ten minutes after vaccination was given.; salivatory glands in mouth dried up, felt like sucking on lemons, nostrils became stuffed up. This was with in about ten minutes after vaccination was given.; The initial spontaneous report information received from a contactable consumer (patient) on 23Mar2021 safety information received was reporting only non-serious adverse drug reactions. Upon receipt of follow-up information on 28Mar2021, this case now contains serious adverse reactions. A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and lot number: EP7534) via an unspecified route of administration to right arm on 22Mar2021 15:00 at single dose for COVID-19 immunization. Patient medical history included high blood pressure, lymes disease, dengue fever, artheritis, known allergies: bees, known allergies: mold, botox and known allergies: some meds. Concomitant medications included lisinopril, vitamins nos and ascorbic acid, thiamine hydrochloride (VITAMIN B AND C COMPLEX). On 22Mar2021 patient reported with salivatory glands in mouth dried up, felt like sucking on lemons, nostrils became stuffed up. This was within about ten minutes after vaccination was given. Patient took benadryl and was observed for 30 min for the events. On 26Mar2021 20:00 patient experienced with distance vision loss began happening four days after being vaccinated patient did not received any treatment for this event. Outcome of event Vision loss was not recovered and Recovered with sequel for other events.  No further information is expected.
Felt weak and tired by late afternoon. Chills in the early to late eve. Then acute nausea from midnight till 2pm. Finally broke a sweat around 330am.  Was fine by 6 am.
headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache".  Additional information: Patient was claiming that the symptom that he was experiencing is not related with the vaccine. Patient only wants to know what pain medication can he took for headache.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning an 11 year old female who in January 2008 was vaccinated with GARDASIL. Concomitant therapy included MENACTRA and diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid. The physician reported that almost immediately after the vaccination the patient experienced "dizziness and felt like she was going to faint". No lot number was provided and no further information was provided. The physician reported that the patient was fine after waiting a little while. Additional information has been requested.
pt recvd vax  & parent reported pt passed out 5 to 10mins p/vax in MD ofc;no fever, BP OK;MD reported that 5 mins p/vax pt fell to the floor w/a LOC for a few seconds;2hrs later pt's mom phoned MD-dizziness, hot, clammy;dx OM & croup
Within 5 mins of shot I had a metallic taste in my mouth then my throat started swelling up, my chest started to feel pressure (tighten) and I started to itch like something crawling on me.  No rash.  I mentioned to the EMTs.  I chewed up a Benadryl.  EMTs stayed with me just in case.  Within 30 mins the symptoms started to go away.
Chest pain for about 60 minutes until I took Advil. It was extremely uncomfortable as I would rate it at 8/10 on a pain scale for about 20 minutes. Also mild body aches and headache.
Developed redness, itching, pain, swelling to (L) upper arm within 24 hrs of vaccine. Treated for cellulitis.
Patient Initially Received vaccine in right deltoid. Due to movement of the child, only 1 ML was administered. Since the syringe was a retractable single use then a new pre-filled was used and .1ML as remainder was given in the Left Deltoid.
Left armpit & clavicular lymph node pain and swelling started on 1/13/21.  Currently it is only slightly tender and tender.
Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Severe, Additional Details: Patient reported devloping a widespread rash on trunk of body abour 3 hrs after receiving her 3rd covid vaccine shot. No issues with 1st & 2nd doses. Sent pt to urgent care to be evaluated further.